Aquestive Therapeutics Inc
AQST
$5.34-0.19%
End of day · as of Sep 7, 2026, 4:32 PM ET
Mkt cap
$493.02M
EV/Sales
8.97
P/E ratio
N/A
FY2025 Revenue
$44.55M
EPS (TTM)
$-0.66
Gross Margin (FY2025)
58.35%
Profit Margin (FY2025)
-188.09%
Beta
1.50
Div yield
N/A
Sector
Healthcare
Aquestive Therapeutics Inc (AQST) is a drug manufacturers - specialty & generic company listed on US.
Latest reported AQST revenue for 2025-12-31 was $44.5M. Net income was -$83.8M. Revenue was down 22.6% from 2024-12-31 to 2025-12-31. AQST currently screens at market cap $493.0M.
Use this AQST research hub for sector, financials, and filings — not a live tape.
Latest cached year on this hub. Full AQST income, balance, and cash tables.
Aquestive Therapeutics Inc (AQST) is a drug manufacturers - specialty & generic company in the Healthcare sector.
Latest cached Aquestive Therapeutics Inc (AQST) revenue for Dec 31, 2025 was $44.5M. Net income was -$83.8M. Statements: https://lician.com/financials/aqst
Aquestive Therapeutics Inc (AQST) market capitalization is $493.0M on the latest cached snapshot.
Aquestive Therapeutics Inc (AQST) cached previous close $5.35; day range $5.29 – $5.49; volume 2,117,771. Session quote: https://lician.com/quote/aqst
Aquestive Therapeutics Inc (AQST) latest cached earnings event is "AQST earnings" on Aug 11, 2026. Earnings calendar: https://lician.com/earnings
The latest cached AQST filing is 8-K · Oct 15, 2026. Filings: https://lician.com/sec/aqst